Literature DB >> 11303019

Radiofrequency catheter ablation of supraventricular arrhythmias.

H Calkins1.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11303019      PMCID: PMC1729737          DOI: 10.1136/heart.85.5.594

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  20 in total

1.  Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current.

Authors:  W M Jackman; X Z Wang; K J Friday; C A Roman; K P Moulton; K J Beckman; J H McClelland; N Twidale; H A Hazlitt; M I Prior
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

2.  Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test.

Authors:  H Calkins; J Sousa; R el-Atassi; S Rosenheck; M de Buitleir; W H Kou; A H Kadish; J J Langberg; F Morady
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

3.  Electrogram criteria for identification of appropriate target sites for radiofrequency catheter ablation of accessory atrioventricular connections.

Authors:  H Calkins; Y N Kim; S Schmaltz; J Sousa; R el-Atassi; A Leon; A Kadish; J J Langberg; F Morady
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

4.  Reduction in medical care cost associated with radiofrequency catheter ablation of accessory pathways.

Authors:  M de Buitleir; J Sousa; S F Bolling; R el-Atassi; H Calkins; J J Langberg; W H Kou; F Morady
Journal:  Am J Cardiol       Date:  1991-12-15       Impact factor: 2.778

5.  Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group.

Authors:  H Calkins; P Yong; J M Miller; B Olshansky; M Carlson; J P Saul; S K Huang; L B Liem; L S Klein; S A Moser; D A Bloch; P Gillette; E Prystowsky
Journal:  Circulation       Date:  1999-01-19       Impact factor: 29.690

6.  Elimination of atrioventricular nodal reentrant tachycardia using discrete slow potentials to guide application of radiofrequency energy.

Authors:  M Haissaguerre; F Gaita; B Fischer; D Commenges; P Montserrat; C d'Ivernois; P Lemetayer; J F Warin
Journal:  Circulation       Date:  1992-06       Impact factor: 29.690

7.  Prevalence and characteristics of escape rhythms after radiofrequency ablation of the atrioventricular junction: results from the registry for AV junction ablation and pacing in atrial fibrillation. Ablate and Pace Trial Investigators.

Authors:  A B Curtis; S P Kutalek; M Prior; T T Newhouse
Journal:  Am Heart J       Date:  2000-01       Impact factor: 4.749

8.  Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow-pathway conduction.

Authors:  W M Jackman; K J Beckman; J H McClelland; X Wang; K J Friday; C A Roman; K P Moulton; N Twidale; H A Hazlitt; M I Prior
Journal:  N Engl J Med       Date:  1992-07-30       Impact factor: 91.245

9.  Safety, feasibility and cost of outpatient radiofrequency catheter ablation of accessory atrioventricular connections.

Authors:  S J Kalbfleisch; R el-Atassi; H Calkins; J J Langberg; F Morady
Journal:  J Am Coll Cardiol       Date:  1993-03-01       Impact factor: 24.094

10.  Radiofrequency catheter ablation of the atrioventricular junction from the left ventricle.

Authors:  J Sousa; R el-Atassi; S Rosenheck; H Calkins; J Langberg; F Morady
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

View more
  3 in total

Review 1.  Novel mapping techniques for cardiac electrophysiology.

Authors:  Paul A Friedman
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

2.  Radiofrequency catheter ablation of supraventricular tachycardia.

Authors:  Hugh Calkins; V K Ajit Kumar; Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2002-04-01

3.  Frequent inappropriate implantable cardioverter defibrillator therapy was determined to be dual atrioventricular nodal non-reentrant tachycardia: A case report.

Authors:  Chengming Ma; Xiaomeng Yin; Yunlong Xia; Wenwen Li; Lianjun Gao; Shiyu Dai; Xiaohong Yu
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.